• / Free eNewsletters & Magazine
  • / My Account
Home>Companies>GlaxoSmithKline

GlaxoSmithKline

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  6. Research
  1. US Healthcare Advertising 2017-2021: Increasing Presence of Generic and Me-too Drugs - Major Players are Johnson & Johnson, Pfizer, Merck & Co., GlaxoSmithKline and Roche - Research and Markets

    US Healthcare Advertising 2017-2021: Increasing Presence of Generic and Me-too Drugs - Major Players are Johnson & Johnson, Pfizer, Merck & Co., GlaxoSmithKline and Roche - Research and Markets

  2. Innoviva Urges Shareholders to Vote “FOR” All of Innoviva’s Value-Creating Directors On the WHITE Proxy Card TODAY

    Innoviva Urges Shareholders to Vote “FOR” All of Innoviva’s Value-Creating Directors On the WHITE Proxy Card TODAY

  3. Cachexia - Pipeline Review, H1 2017 Featuring Aphios, GlaxoSmithKline , MYOS RENS Technology, Novartis, Teijin Pharma & VBS Pharmaceuticals - Research and Markets

    Cachexia - Pipeline Review, H1 2017 Featuring Aphios, GlaxoSmithKline , MYOS RENS Technology, Novartis, Teijin Pharma & VBS Pharmaceuticals - Research and Markets

  4. Teeth Whitening Market - Drivers and Forecasts by Technavio

    Teeth Whitening Market - Drivers and Forecasts by Technavio

  5. Prescription-drug Shortages Help Push Up Prices of Similar Drugs

    Prescription-drug Shortages Help Push Up Prices of Similar Drugs

  6. Global Oral Care Market (Toothbrush, Tooth Whitener, Denture Care and Toothpaste) Size, Trends & Forecasts 2017-2021 - Research and Markets

    Global Oral Care Market (Toothbrush, Tooth Whitener, Denture Care and Toothpaste) Size, Trends & Forecasts 2017-2021 - Research and Markets

  7. BMW, Glaxo and Allstate Join Advertisers Withdrawing From O'Reilly's Show -- Update

    BMW, Glaxo and Allstate Join Advertisers Withdrawing From O'Reilly's Show -- Update

  8. Glaxo's New Chief Steps Into the Fray -- WSJ

    Glaxo's New Chief Steps Into the Fray -- WSJ

  9. Antibacterial Therapies Drug Development Pipeline Review 2017 - Research and Markets

    Antibacterial Therapies Drug Development Pipeline Review 2017 - Research and Markets

  10. UPDATE: Gold is marching toward $1,300 -- but this could trip it up

    UPDATE: Gold is marching toward $1,300 -- but this could trip it up

12345

©2017 Morningstar Advisor. All right reserved.